The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Safonova T.N.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Gladkova O.V.

Research Institute of Eye Diseases, 11 A, B, Rossolimo St., Moscow, Russian Federation, 119021

Boev V.I.

Research Institute of Eye Diseases, 11 A, B, Rossolimo St., Moscow, Russian Federation, 119021

Fedorov A.A.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Effectiveness of soft contact lenses in severe keratoconjunctivitis sicca treated with local immunosuppressive therapy

Authors:

Safonova T.N., Gladkova O.V., Boev V.I., Fedorov A.A.

More about the authors

Journal: Russian Annals of Ophthalmology. 2016;132(5): 39‑48

Read: 2421 times


To cite this article:

Safonova TN, Gladkova OV, Boev VI, Fedorov AA. Effectiveness of soft contact lenses in severe keratoconjunctivitis sicca treated with local immunosuppressive therapy. Russian Annals of Ophthalmology. 2016;132(5):39‑48. (In Russ.)
https://doi.org/10.17116/oftalma2016132539-48

References:

  1. Bhavsar АS, Bhavsar SG, Jain SM. A review on recent advances in dry eye:Pathogenesis and management. Oman J Ophthalmol. 2011;4(2):50-56. doi: 10.4103/0974-620x.83653
  2. Dogru M, Tsubota K. Pharmacotherapy of dry eye. Expert Opin Pharmacother. 2011;12(3):325-334. doi: 10.1517/14656566.2010.518612
  3. Devecı H., Kobak S. The efficacy of topical 0.05% cyclosporine A in patients with dry eye disease associated with Sjögren's syndrome. Int Ophthalmol. 2014;34 (5):32—39. doi: 10.1007/s10792-014-9901-4
  4. Donnenfeld E, Pflugfelder SC. Topical ophthalmic cyclosporine:pharmacology and clinical uses. Surv Ophthalmol. 2009;54(3):321-338. doi: 10.1016/j.survophthal.2009.02.002
  5. Brzheskij V, Majchuk D. New possibilities of immunosuppressive therapy in patients with dry eye syndrome. Oftal'mologicheskie vedomosti. 2012;1(5):69-74. (In Russ.)
  6. Ragam A, Kolomeyer AM, Kim JS, Nayak NV, Fang C, Kim E, Chu DS. Topical cyclosporine a 1% for the treatment of chronic ocular surface inflammation. Eye Contact Lens. 2014;40(5):283-288. doi: 10.1097/icl.0000000000000055
  7. Majchuk D, Vahova E, Majchuk Ju. Application of liposomal cyclosporine — cycloolip eye drops in the treatment of inflammatory diseases of the eye. Novye lekarstvennye preparaty. 1998;10:29-32. (In Russ.)
  8. Rosenthal P, Cotter JM, Baum J. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable sclera contact lens. Am J Ophthalmol. 2000;130(1):33-41. doi: 10.1016/s0002-9394(00)00379-2
  9. Romero-Rangel T, Stavrou P, Cotter J, Rosenthal P, Baltatzis S, Foster CS. Gas-permeable scleral contact lens therapy in ocular surface disease. Am J Ophthalmol. 2000;130(1):25-32. doi: 10.1016/s0002-9394(00)00378-0
  10. Safonova T, Vasil'ev V, Lihvanceva V. Sindrom Shegrena. Rukovodstvo dlja vrachej. Moscow: Publisher University of Moscow; 2013. (In Russ.)
  11. Egorova G, Mitichkina T, Fedorov A.A., Shamsudinova A.R. Use of an emulsion of cyclosporin for correcting the ocular surface changes when wearing contact lenses. Vestnik oftal'mologii. 2015;131(1):95-101. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.